Centene Co. (NYSE:CNC) Shares Purchased by Stifel Financial Corp

Stifel Financial Corp boosted its position in Centene Co. (NYSE:CNCFree Report) by 31.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 148,354 shares of the company’s stock after purchasing an additional 35,352 shares during the quarter. Stifel Financial Corp’s holdings in Centene were worth $11,009,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CNC. Hohimer Wealth Management LLC boosted its position in Centene by 1.1% during the fourth quarter. Hohimer Wealth Management LLC now owns 12,020 shares of the company’s stock worth $892,000 after acquiring an additional 131 shares during the last quarter. Sandy Spring Bank increased its holdings in shares of Centene by 10.1% in the fourth quarter. Sandy Spring Bank now owns 1,629 shares of the company’s stock valued at $121,000 after purchasing an additional 150 shares during the last quarter. First Bank & Trust lifted its position in Centene by 4.1% during the fourth quarter. First Bank & Trust now owns 4,154 shares of the company’s stock worth $308,000 after buying an additional 162 shares in the last quarter. Blue Trust Inc. boosted its stake in Centene by 7.2% during the fourth quarter. Blue Trust Inc. now owns 2,454 shares of the company’s stock worth $169,000 after buying an additional 164 shares during the last quarter. Finally, Cornercap Investment Counsel Inc. increased its stake in shares of Centene by 0.5% in the 4th quarter. Cornercap Investment Counsel Inc. now owns 32,396 shares of the company’s stock worth $2,404,000 after acquiring an additional 174 shares during the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.

Insider Buying and Selling

In other Centene news, Director Christopher J. Coughlin sold 878 shares of the business’s stock in a transaction that occurred on Tuesday, May 14th. The shares were sold at an average price of $76.75, for a total transaction of $67,386.50. Following the completion of the transaction, the director now owns 25,504 shares in the company, valued at approximately $1,957,432. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In related news, President Kenneth J. Fasola sold 8,000 shares of the company’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $77.62, for a total value of $620,960.00. Following the completion of the transaction, the president now directly owns 300,357 shares of the company’s stock, valued at $23,313,710.34. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Christopher J. Coughlin sold 878 shares of the firm’s stock in a transaction that occurred on Tuesday, May 14th. The stock was sold at an average price of $76.75, for a total transaction of $67,386.50. Following the sale, the director now directly owns 25,504 shares in the company, valued at approximately $1,957,432. The disclosure for this sale can be found here. Insiders own 0.29% of the company’s stock.

Centene Price Performance

Shares of CNC opened at $69.70 on Thursday. The company has a market cap of $37.20 billion, a P/E ratio of 13.86, a PEG ratio of 0.92 and a beta of 0.47. Centene Co. has a fifty-two week low of $60.83 and a fifty-two week high of $81.42. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.66. The firm’s 50 day moving average price is $74.44 and its 200 day moving average price is $75.56.

Centene (NYSE:CNCGet Free Report) last posted its quarterly earnings data on Friday, April 26th. The company reported $2.26 earnings per share for the quarter, topping analysts’ consensus estimates of $2.09 by $0.17. Centene had a return on equity of 14.19% and a net margin of 1.76%. The business had revenue of $40.41 billion for the quarter, compared to analyst estimates of $36.43 billion. During the same quarter in the prior year, the company earned $2.11 earnings per share. The company’s revenue was up 3.9% on a year-over-year basis. On average, research analysts forecast that Centene Co. will post 6.82 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on CNC. Barclays upped their price objective on shares of Centene from $101.00 to $104.00 and gave the company an “overweight” rating in a report on Thursday, May 2nd. Oppenheimer restated an “outperform” rating and set a $110.00 price target on shares of Centene in a report on Monday, April 29th. Wells Fargo & Company upped their price objective on Centene from $89.00 to $93.00 and gave the company an “overweight” rating in a report on Monday, April 15th. Baird R W raised Centene to a “hold” rating in a research note on Thursday, May 30th. Finally, Robert W. Baird assumed coverage on Centene in a research note on Thursday, May 30th. They issued a “neutral” rating and a $83.00 price target on the stock. Eight equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $84.93.

Get Our Latest Stock Report on CNC

About Centene

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Further Reading

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.